These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7734715)

  • 21. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
    Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
    Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
    Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
    Pui CH; Rubnitz JE; Hancock ML; Downing JR; Raimondi SC; Rivera GK; Sandlund JT; Ribeiro RC; Head DR; Relling MV; Evans WE; Behm FG
    J Clin Oncol; 1998 Dec; 16(12):3768-73. PubMed ID: 9850020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-lineage expression in 505 patients with acute lymphoblastic leukemia by multiparametric flow cytometry analysis.
    Wang XB; Du W; Xia L; Zheng JE; Liu J; He YL; Sun ZM; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1419-23. PubMed ID: 20030918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
    Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
    Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
    Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
    Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
    BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
    Amirghofran Z; Daneshbod Y; Gholijani N
    Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
    Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
    Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia].
    Chen GB; Tang MH; Yang TY
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33 acute lymphoblastic leukaemias in vitro and in vivo.
    Golay J; Di Gaetano N; Amico D; Cittera E; Barbui AM; Giavazzi R; Biondi A; Rambaldi A; Introna M
    Br J Haematol; 2005 Feb; 128(3):310-7. PubMed ID: 15667532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
    De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
    Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin and T-cell receptor gene rearrangements in acute lymphoblastic leukemia--a higher incidence of double rearrangements in patients with myeloid antigen expression.
    Tien HF; Wang CH; Su IJ; Wu HS; Chien SH; Chen YC; Lin DT; Lin KH; Shen MC
    Leuk Res; 1991; 15(2-3):91-8. PubMed ID: 1850056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
    Den Boer ML; Kapaun P; Pieters R; Kazemier KM; Janka-Schaub GE; Veerman AJ
    Br J Haematol; 1999 Jun; 105(4):876-82. PubMed ID: 10554796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic classification used in typing of 68 cases of acute leukemias].
    Sun XL; Fang MY; Jiang F; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):39-41. PubMed ID: 16584588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
    Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
    J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia.
    Krance RA; Raimondi SC; Dubowy R; Estrada J; Borowitz M; Behm F; Land VJ; Pullen J; Carroll AJ
    Leukemia; 1992 Apr; 6(4):251-5. PubMed ID: 1534130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
    Abdelhaleem M
    Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
    Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
    Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.